Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

41,479 stories, page 447 of 692

Advanced search

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Gerresheimer Starts Operations at New Plant in Zhenjiang Dagang, China

Sustainable Packaging NewsOriginal source

🌍Jul 23discoverynews.google.comTier 2 · Trade media

Lilly, with new data, to seek FDA approval of obesity drug retatrutide

BioPharma DiveOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Tranche Update on West Pharmaceutical Services, Inc.'s Equity Buyback Plan announced on February 17, 2026.

marketscreener.comOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical CEO Highlights GLP-1 And Biologics Momentum

BenzingaOriginal source

🌍Jul 23discoverynews.google.comTier 2 · Trade media

GSK secures first lung cancer approval, validating $10.6bn Nuvalent bet

Pharmaceutical TechnologyOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Breaking News: Eli Lilly pays $38M to secure land for massive West Creek pharma facility

Richmond BizSenseOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Fugitive doctor on run for 21 years was living as an L.A. biotech executive

MyHighPlains.comOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

West Pharma raises profit forecast on strong demand for injectable drug components

ReutersOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Legislation to Cap Insulin Prices, Improve Drug Safety, and Speed Access to Biosimilars Passes Senate HELP Committee

NAVLIN DAILYOriginal source

🌍Jul 23discoverynews.google.comTier 2 · Trade media

FDA panel confronting peptide controversy

STATOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Jyong Biotech pursues global licensing partnerships for BPH drug

Investing.comOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Jyong Biotech Ltd. Reaffirms Global Licensing Strategy for Botanical BPH Drug Candidate Botreso

Quiver QuantitativeOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Why is West Pharmaceutical Services stock surging today? By Investing.com

Investing.com NigeriaOriginal source

🇺🇰Jul 23Regulatorygov.ukTier 1 · Regulatory source

Monthly mandatory surveillance of MRSA, MSSA, Gram-negative bacteraemia and C. difficile infections, June 2025 to June 2026

Mandatory surveillance of healthcare-associated infections (HCAI), which include methicillin-resista...

UK Health Security AgencyOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Jyong Biotech Highlights Multi-Billion Dollar Global BPH

GlobeNewswireOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

marketscreener.comOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of TELCON RF PHARMACEUTICAL. Inc. – KRX:200230

TradingViewOriginal source

🇨🇦Jul 23Researchwomenscollegehospital.caTier 2 · Direct publisher

Women’s College Hospital Scientists Secure Five CIHR Project Grants

Women's College HospitalOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Why is West Pharmaceutical Services stock surging today?

Investing.comOriginal source

🇺🇰Jul 23Industrycongenica.comTier 1 · Company source

Your Migration to the SeqOne Platform

CongenicaOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Mid-Year Check-In: Is Patient Affordability Getting Worse?

Pharmaceutical CommerceOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBITDA forward of Epi Biotech Co., Ltd. – KRX:446440

TradingViewOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Mabion and KriSan Biotech Launch Partnership for Next-Gen ADCs

CHEManagerOriginal source

🌍Jul 23discoverynews.google.comTier 2 · Trade media

Scancell to go public after winning reverse merger bid for troubled Neuphoria

Fierce BiotechOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

WATCH: FDA advisory panel narrowly backs use of several peptides favored by RFK Jr.

PBSOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

PulsePoint and CMI Media Group Launch the First Agency Activation of HCP2DTC Influence™

TradingViewOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Most-Wanted Fugitive Hid Out For 21 Years As A Biotech Exec

Investor's Business DailyOriginal source

🌍Jul 23discoverynews.google.comTier 2 · Trade media

Biogen bets newly acquired Apellis can paper over Leqembi's disappointing sales into 2027

Endpoints NewsOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

IntrepidX Adds Hatch-Waxman eDiscovery Leader Taylor Judd to Expand Pharmaceutical Litigation and Corporate Legal Growth

EIN NewsOriginal source

🇩🇰Jul 23Associationnovonordiskfonden.dkTier 2 · Direct publisher

Towards coherent landscapes: New natural and afforestation areas are taking shape in Denmark

Novo Nordisk Foundation (News)Original source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

An AI Biotech Just Reported a 46% Revenue Jump and Its First Recurring Platform Contracts, as Its Pivot Starts Showing Up in the Numbers

MorningstarOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Lilly’s triple agonist, retatrutide, successful in two additional Phase 3 obesity trials

PharmaLiveOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Eli Lilly Is Acquiring a Psychedelic Medicine Biotech. Here's What You Need to Know.

The Motley FoolOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Earnings call transcript: West Pharmaceutical beats Q2 2026 estimates, lifts outlook

Investing.comOriginal source

🇺🇸Jul 23CROmedpace.comTier 2 · Direct publisher

Alport Research Hub Symposium: From Bench to Bedside

MedpaceOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

FDA inspects BMC headquarters canteen, suspends its registration over food safety violations

Mid-DayOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical (WST) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Yahoo FinanceOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Full Transcript: West Pharmaceutical Servs Q2 2026 Earnings Call

BenzingaOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Egyptian Biotech Reme-D Raises USD 1.45 M Pre-Series A To Expand Molecular Diagnostics

WeeTrackerOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

What to know about the 7 peptides being reviewed by an FDA panel

NBC4 WashingtonOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Earnings call transcript: West Pharmaceutical beats Q2 2026 estimates, lifts outlook

Investing.comOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Eli Lilly Is Acquiring a Psychedelic Medicine Biotech. Here's What You Need to Know.

Yahoo FinanceOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

An AI Biotech Just Reported a 46% Revenue Jump and Its First Recurring Platform Contracts, as Its Pivot Starts Showing Up in the Numbers

PR NewswireOriginal source

🌍Jul 23Industryabelzeta.comTier 1 · Company source

Publication in Nature journal highlighting clinical findings for an armored autologous GPC3 CAR-T therapy in patients with advanced HCC

AbelZeta PharmaOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Level of attention and its effects on risk of confusion and dilution: recent EU case law

Wolters KluwerOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Which iShares Healthcare ETF Is the Better Buy: Diversified IXJ or Biotech-Focused IBB?

The Motley FoolOriginal source

🇺🇸Jul 23Industryjnj.comTier 1 · Company source

TECVAYLI® + TALVEY® reduced the risk of disease progression or death by 89% and the risk of death by 62% in earlier-line relapsed/refractory multiple myeloma

· Investigational MonumenTAL-6 trial is the first and only Phase 3 study of a dual antigen, BCMA and...

Johnson & Johnson NewsOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

US FDA panel weighs injectable peptides as experts demand gray market guardrails

Personal Care InsightsOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Canton Strategic (NASDAQ: CNTN) exits Gravitas biotech arm with $3.5M note

Stock TitanOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Why is West Pharmaceutical Services stock surging today?

Investing.comOriginal source

🇪🇺Jul 23Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: OmegaTree: MAS-10® Enabled Metabolomics and AI-Driven Precision Nutrition and Health Analytics Platform

CORDISOriginal source

🇪🇺Jul 23Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: AI-POWERED PREDICTION OF CANCER THERAPY RESPONSE USING ULTRASOUND SHEAR WAVE ELASTOGRAPHY

CORDISOriginal source

🇪🇺Jul 23Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Unlocking Multi‑Omics Analytics for European Precision Medicine

CORDISOriginal source

🇪🇺Jul 23Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Advancing Affordable, Immune-Based Multi-Cancer Early Detection

CORDISOriginal source

🇪🇺Jul 23Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Immuno-Modulatory Platform for Advanced CLL Therapy

CORDISOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Eli Lilly Moves Closer To Another Weight-Loss Drug: Retatrutide Clears Two More Phase 3 Trials Ahead Of FDA Filing

Asianet NewsableOriginal source

🌍Jul 23discoverynews.google.comTier 2 · Trade media

FDA clears Johnson & Johnson’s surgical robot for ‘the next era in surgery’

Fierce BiotechOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services (NYSE:WST) Beats Expectations in Strong Q2 CY2026, Stock Soars

StockStoryOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

Eli Lilly Moves Closer To Another Weight-Loss Drug: Retatrutide Clears Two More Phase 3 Trials Ahead Of FDA Filing

StocktwitsOriginal source

🌍Jul 23discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services Releases Q2 2026 Financial Results

AlphaStreetOriginal source